Gli1, a potential cancer stem cell marker, is strongly associated with prognosis in prostate cancer

Autor Lv, Lili, Yang, Zhaoting, Ma, Tonghui, Xuan, Yanhua
Vydáno v Int J Clin Exp Pathol (2018)

LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma

Autor Piao, Longzhen, Yang, Zhaoting, Feng, Ying, Zhang, Chengye, Cui, Chunai, Xuan, Yanhua
Vydáno v BMC Cancer (2019)

Tenascin-C predicts poor outcomes for patients with colorectal cancer and drives cancer stemness via Hedgehog signaling pathway

Autor Yang, Zhaoting, Zhang, Chengye, Feng, Ying, Quan, Mingji, Cui, Yan, Xuan, Yanhua
Vydáno v Cancer Cell Int (2020)

Gli1 regulates stemness characteristics in gastric adenocarcinoma

Autor Qi, Wenbo, Yang, Zhaoting, Feng, Ying, Li, Haoyue, Che, Nan, Liu, Lan, Xuan, Yanhua
Vydáno v Diagn Pathol (2020)

Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy

Autor Che, Nan, Yang, Zhaoting, Liu, Xingzhe, Li, Mengxuan, Feng, Ying, Zhang, Chengye, Li, Chao, Cui, Yan, Xuan, Yanhua
Vydáno v J Cell Mol Med (2020)

3D culture technologies of cancer stem cells: promising ex vivo tumor models

Autor Zhang, Chengye, Yang, Zhaoting, Dong, Da-Long, Jang, Tae-Su, Knowles, Jonathan C., Kim, Hae-Won, Jin, Guang-Zhen, Xuan, Yanhua
Vydáno v J Tissue Eng (2020)